• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Stepan Company filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    5/5/25 7:00:08 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $SCL alert in real time by email
    8-K
    0000094049false00000940492025-05-052025-05-05

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): May 05, 2025

     

     

    STEPAN COMPANY

    (Exact name of Registrant as Specified in Its Charter)

     

     

    Delaware

    1-4462

    36-1823834

    (State or Other Jurisdiction
    of Incorporation)

    (Commission File Number)

    (IRS Employer
    Identification No.)

     

     

     

     

     

    1101 Skokie Boulevard

    Suite 500

     

    Northbrook, Illinois

     

    60062

    (Address of Principal Executive Offices)

     

    (Zip Code)

     

    Registrant’s Telephone Number, Including Area Code: 847 446-7500

     

     

    (Former Name or Former Address, if Changed Since Last Report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:


    Title of each class

     

    Trading
    Symbol(s)

     


    Name of each exchange on which registered

    Common Stock, $1 par value

     

    SCL

     

    The New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     


    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    Stepan Company (“Stepan”) held its Annual Meeting of Stockholders on April 29, 2025 (the “Annual Meeting”). At the Annual Meeting, Stepan’s stockholders approved the Stepan Company 2022 Equity Incentive Compensation Plan (As Amended and Restated Effective April 29, 2025) (the “Plan”), which was adopted by the Company’s Board of Directors on February 18, 2025, subject to stockholder approval. The Plan became effective on April 29, 2025. A description of the terms and conditions of the Plan is set forth under the heading “Proposal No. 4: Approve the Amendment and Restatement of the Stepan Company 2022 Equity Incentive Compensation Plan” in Stepan’s Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on March 25, 2025, which description is incorporated herein by reference. The description of the Plan incorporated herein by reference does not purport to be complete and is qualified in its entirety by reference to the full text of the Plan, which is attached as Exhibit 10.1 hereto and incorporated herein by reference.

    Item 5.07 Submission of Matters to a Vote of Security Holders.

    At the Annual Meeting, there were 20,098,689 shares of Stepan’s common stock represented to vote either in person or by proxy, which represented a quorum. Stockholders voted on the following matters at the Annual Meeting: (1) election of two nominees to serve as directors until the annual meeting of stockholders to be held in 2028; (2) an advisory vote to approve the compensation of Stepan’s named executive officers; (3) ratification of the appointment of Deloitte & Touche LLP as Stepan’s independent registered public accounting firm for fiscal year 2025; and (4) approval of the amendment and restatement of the Stepan Company 2022 Equity Incentive Compensation Plan.

     

     

    Set forth below are the matters acted upon at the Annual Meeting and final voting results on each such matter as reported by Stepan’s inspector of elections.

     

    Proposal 1: Election of Directors

     

    NAME

    FOR

    AGAINST

    ABSTAIN

    BROKER NON-VOTES

    Lorinda A. Burgess

    17,711,569

    389,891

    15,444

    1,981,785

    Luis E. Rojo

    17,914,304

    199,082

    3,518

    1,981,785

     

    Proposal 2: Advisory Vote to Approve the Compensation of Stepan’s Named Executive Officers

     

    FOR

    AGAINST

    ABSTAIN

    BROKER NON-VOTES

    17,431,991

    335,992

    348,921

    1,981,785

     

    Proposal 3: Ratification of the Appointment of Deloitte & Touche LLP as Stepan’s Independent Registered Public Accounting Firm for 2025

     

    FOR

    AGAINST

    ABSTAIN

    19,546,631

    538,530

    13,528

     

    Proposal 4: Approval of the amendment and restatement of the Stepan Company 2022 Equity Incentive Compensation Plan

     

    FOR

    AGAINST

    ABSTAIN

    BROKER NON-VOTES

    16,752,352

    1,005,426

    359,126

    1,981,785

     


    Item 9.01 Financial Statements and Exhibits.

    (d) Exhibits

     

    Exhibit Number: 10.1

    Description: Stepan Company 2022 Equity Compensation Plan (As Amended and Restated Effective April 29, 2025).

     

     

    Exhibit Number: 104

    Description: Cover Page Interactive Data File (embedded within the Inline XBRL document)

     


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

     

     

    STEPAN COMPANY

     

     

     

     

    Date:

    May 5, 2025

    By:

    /s/ Kamel Aranki

     

     

     

    Kamel Aranki
    Interim General Counsel and Interim Assitant Secretary

     


    Get the next $SCL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SCL

    DatePrice TargetRatingAnalyst
    10/19/2023$89.00Neutral → Buy
    CL King
    3/11/2022$9.00 → $8.00Outperform
    RBC Capital
    12/20/2021$8.50 → $9.00Outperform
    RBC Capital
    More analyst ratings

    $SCL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Lewis Susan bought $31,765 worth of shares (500 units at $63.53), increasing direct ownership by 36% to 1,896 units (SEC Form 4)

      4 - STEPAN CO (0000094049) (Issuer)

      2/27/25 8:57:39 AM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary
    • VP GC & Secretary Kabbes David bought $75,388 worth of shares (1,056 units at $71.39) (SEC Form 4)

      4 - STEPAN CO (0000094049) (Issuer)

      8/15/24 1:19:55 PM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary

    $SCL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Stepan Announces Agreement to Sell Philippine Assets

      NORTHBROOK, Ill., May 27, 2025 /PRNewswire/ -- Stepan Company (NYSE: SCL) today announced that its subsidiary, Stepan Philippines Quaternaries, Inc. (SPQI), has entered into an agreement to sell SPQI's manufacturing assets located in Bauan, Batangas, Philippines to Masurf, Inc., a subsidiary of Musim Mas Holdings Pte. Ltd. "The sale of this facility aligns with our strategy to focus on core growth areas; our global manufacturing network and the tolling relationship with Masurf after the transaction closes will allow us to continue to service and grow with our broad customer ba

      5/27/25 8:00:00 AM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Stepan Reports First Quarter 2025 Results

      NORTHBROOK, Ill., April 29, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: First Quarter 2025 Highlights Reported net income was $19.7 million, up 42% versus the prior year. Adjusted net income(1) was $19.3 million, up 32% versus the prior year.EBITDA(2) was $58.0 million and Adjusted EBITDA(2) was $57.5 million, up 16% and 12% respectively, year-over-year.Global sales volume was up 4% year-over-year.Cash from Operations was $6.9 million during the quarter. Free cash flow(3) for the quarter was a negative $25.8 million driven by higher working capital to suppor

      4/29/25 7:00:00 AM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Stepan Declares Quarterly Dividend

      NORTHBROOK, Ill., April 29, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: The Board of Directors of Stepan Company has declared a quarterly cash dividend on the Company's common stock of $0.385 per share. The dividend is payable on June 13, 2025, to common stockholders of record on May 30, 2025. The Company increased its quarterly cash dividend in the fourth quarter of 2024 by $0.010 per share, marking the 57th consecutive year that the Company has increased its cash dividend to stockholders. Corporate Profile Stepan Company is a major manufacturer of specialt

      4/29/25 7:00:00 AM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary

    $SCL
    Financials

    Live finance-specific insights

    See more

    $SCL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Stepan Reports First Quarter 2025 Results

      NORTHBROOK, Ill., April 29, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: First Quarter 2025 Highlights Reported net income was $19.7 million, up 42% versus the prior year. Adjusted net income(1) was $19.3 million, up 32% versus the prior year.EBITDA(2) was $58.0 million and Adjusted EBITDA(2) was $57.5 million, up 16% and 12% respectively, year-over-year.Global sales volume was up 4% year-over-year.Cash from Operations was $6.9 million during the quarter. Free cash flow(3) for the quarter was a negative $25.8 million driven by higher working capital to suppor

      4/29/25 7:00:00 AM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Stepan Declares Quarterly Dividend

      NORTHBROOK, Ill., April 29, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: The Board of Directors of Stepan Company has declared a quarterly cash dividend on the Company's common stock of $0.385 per share. The dividend is payable on June 13, 2025, to common stockholders of record on May 30, 2025. The Company increased its quarterly cash dividend in the fourth quarter of 2024 by $0.010 per share, marking the 57th consecutive year that the Company has increased its cash dividend to stockholders. Corporate Profile Stepan Company is a major manufacturer of specialt

      4/29/25 7:00:00 AM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Stepan to Announce First Quarter 2025 Results on April 29, 2025

      NORTHBROOK, Ill., April 14, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) will issue its first quarter 2025 earnings results on Tuesday, April 29, 2025 at approximately 7:00 a.m. ET (6:00 a.m. CT). Supporting slides will be posted at approximately the same time on the Investors/Presentations page at www.stepan.com. The Company will hold a conference call to discuss and answer questions about its financial and operational performance on the same day at 8:00 a.m. ET (7:00 a.m. CT). The call will be hosted by Luis E. Rojo, President and Chief Executive Officer, and Samuel S. Hin

      4/14/25 7:00:00 AM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Stepan Company upgraded by CL King with a new price target

      CL King upgraded Stepan Company from Neutral to Buy and set a new price target of $89.00

      10/19/23 9:02:32 AM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary
    • RBC Capital reiterated coverage on Shawcor with a new price target

      RBC Capital reiterated coverage of Shawcor with a rating of Outperform and set a new price target of $8.00 from $9.00 previously

      3/11/22 7:14:07 AM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary
    • RBC Capital reiterated coverage on Shawcor with a new price target

      RBC Capital reiterated coverage of Shawcor with a rating of Outperform and set a new price target of $9.00 from $8.50 previously

      12/20/21 6:55:29 AM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary

    $SCL
    Leadership Updates

    Live Leadership Updates

    See more
    • Stepan Promotes Luis E. Rojo to President and Chief Executive Officer

      NORTHBROOK, Ill., Oct. 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today announced the appointment of Luis E. Rojo as President and Chief Executive Officer and as a member of the Board of Directors, effective immediately. After a 31-year Stepan career, Scott R. Behrens is departing the Company to pursue other opportunities. "We thank Scott for his leadership and his many contributions to the growth and diversification of Stepan over his career with the Company. During his various roles in R&D, sales and marketing, and leadership, he helped diversify our market presence,

      10/30/24 6:55:00 AM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Stepan Company Announces Appointment of New Director

      NORTHBROOK, Ill., Feb. 15, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) announced today the appointment of Susan M. Lewis as a Director of Stepan, effective on February 15, 2024. Ms. Lewis spent over 30 years at Dow Inc., a materials science company, and was part of the management team of Corteva, Inc., a global agriculture company, following its spinoff from DowDuPont Inc. Ms. Lewis served as Senior Vice President, Global Operations of Corteva from 2018 until her retirement in 2021, after which she worked as a business and executive consultant through 2023. Ms. Lewis held senior management roles with operations, sustainability and risk management responsibilities and led organizational r

      2/15/24 4:30:00 PM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary
    • AVITA Medical, Inc. Appoints Two New Non-Executive Members to the Board of Directors

      VALENCIA, Calif. and MELBOURNE, Australia, June 01, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH))) ("AVITA Medical"), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today the appointment of James Corbett and Jan Stern Reed to its Board of Directors effective July 1, 2021. Mr. Corbett has approximately 40 years of leadership experience in the medical device field, most recently, as CEO of CathWorks Ltd., a software-based medical technology company. Mr. Corbett has extensive global commercial and operating experience, serving as an

      6/1/21 4:01:00 PM ET
      $SCL
      $RCEL
      $ANGO
      Package Goods/Cosmetics
      Consumer Discretionary
      Medical/Dental Instruments
      Health Care

    $SCL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Stepan Company

      SC 13G - STEPAN CO (0000094049) (Subject)

      2/9/24 9:59:18 AM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Stepan Company (Amendment)

      SC 13G/A - STEPAN CO (0000094049) (Subject)

      1/24/24 12:33:12 PM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Stepan Company (Amendment)

      SC 13G/A - STEPAN CO (0000094049) (Subject)

      1/22/24 3:52:11 PM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary

    $SCL
    SEC Filings

    See more
    • SEC Form SD filed by Stepan Company

      SD - STEPAN CO (0000094049) (Filer)

      5/30/25 5:11:57 PM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form 8-K filed by Stepan Company

      8-K - STEPAN CO (0000094049) (Filer)

      5/21/25 4:31:14 PM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SCHEDULE 13G filed by Stepan Company

      SCHEDULE 13G - STEPAN CO (0000094049) (Subject)

      5/13/25 12:17:58 PM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary

    $SCL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: EVP, Supply Chain Haire Robert Joseph covered exercise/tax liability with 162 shares, decreasing direct ownership by 22% to 591 units (SEC Form 4)

      4/A - STEPAN CO (0000094049) (Issuer)

      5/21/25 2:56:47 PM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Director Stepan F Quinn Jr was granted 2,500 shares, increasing direct ownership by 2% to 105,446 units (SEC Form 4)

      4 - STEPAN CO (0000094049) (Issuer)

      5/14/25 6:33:13 PM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Director Dearth Randall S. was granted 2,500 shares, increasing direct ownership by 22% to 14,106 units (SEC Form 4)

      4 - STEPAN CO (0000094049) (Issuer)

      5/14/25 5:44:33 PM ET
      $SCL
      Package Goods/Cosmetics
      Consumer Discretionary